Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Emergent Biosolutions Inc.

Start price
Target price
Perf. (%)
€7.40
02.07.24
€7.44
02.07.25
73.76%
26.07.24

Benchmark Co. 
02.07.24 50%
buy
Emergent Biosolutions Inc.

Start price
Target price
Perf. (%)
€6.00
20.06.24
€7.46
20.06.25
114.42%
26.07.24

Benchmark Co. 
20.06.24 50%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€41.51
04.06.24
€46.01
04.06.25
24.74%
26.07.24

HC Wainwright 
04.06.24 50%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€42.05
22.05.24
€46.15
22.05.25
23.14%
26.07.24

HC Wainwright 
22.05.24 50%
buy
United Therapeutics

Start price
Target price
Perf. (%)
€255.10
21.05.24
€276.33
21.05.25
21.60%
25.07.24

JPMorgan Chase & Co. 
21.05.24 50%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€38.39
07.05.24
€46.39
07.05.25
34.88%
26.07.24

HC Wainwright 
07.05.24 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€140.00
02.05.24
€186.38
02.05.25
54.50%
26.07.24

Needham & Company LLC 
02.05.24 50%
buy
United Therapeutics

Start price
Target price
Perf. (%)
€240.60
02.05.24
€280.26
02.05.25
28.93%
25.07.24

HC Wainwright 
02.05.24 50%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€35.70
30.04.24
€46.72
30.04.25
44.65%
26.07.24

HC Wainwright 
30.04.24 50%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€36.23
16.04.24
€46.98
16.04.25
42.53%
26.07.24

Benchmark Co. 
16.04.24 50%
buy
Emergent Biosolutions Inc.

Start price
Target price
Perf. (%)
€2.04
11.04.24
€4.65
11.04.25
530.64%
26.07.24

Benchmark Co. 
11.04.24 50%
buy
Emergent Biosolutions Inc.

Start price
Target price
Perf. (%)
€2.53
07.03.24
€4.58
07.03.25
409.30%
26.07.24

Benchmark Co. 
07.03.24 50%
buy
United Therapeutics

Start price
Target price
Perf. (%)
€220.00
07.03.24
€298.84
07.03.25
41.00%
25.07.24

Wells Fargo & Company 
07.03.24 50%
buy
United Therapeutics

Start price
Target price
Perf. (%)
€202.00
22.02.24
€277.11
22.02.25
53.56%
25.07.24

HC Wainwright 
22.02.24 50%
buy
United Therapeutics

Start price
Target price
Perf. (%)
€202.00
22.02.24
€284.50
22.02.25
53.56%
25.07.24

Wedbush 
22.02.24 50%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€35.80
21.02.24
€46.24
21.02.25
44.64%
26.07.24

HC Wainwright 
21.02.24 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€136.40
16.02.24
€210.72
16.02.25
58.58%
26.07.24

Citigroup Inc. 
16.02.24 50%
buy
Agios Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€24.80
16.02.24
€38.99
16.02.25
79.03%
26.07.24

Royal Bank of Canada 
16.02.24 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€139.00
16.02.24
€209.30
16.02.25
55.61%
26.07.24

Chardan Capital 
16.02.24 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€137.00
15.02.24
€185.66
15.02.25
57.88%
26.07.24

Needham & Company LLC 
15.02.24 50%
buy
United Therapeutics

Start price
Target price
Perf. (%)
€198.35
05.02.24
€307.26
05.02.25
56.39%
25.07.24

SVB Leerink LLC 
05.02.24 50%
buy
Dr. Reddy's Laboratories Ltd. ADR

Start price
Target price
Perf. (%)
€64.00
29.01.24
€73.92
29.01.25
15.63%
25.07.24

Barclays PLC 
29.01.24 50%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€31.35
19.01.24
€45.94
19.01.25
65.17%
26.07.24

Benchmark Co. 
19.01.24 50%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€31.43
18.01.24
€44.22
18.01.25
64.75%
26.07.24

HC Wainwright 
18.01.24 50%
buy
Medpace Holdings Inc

Start price
Target price
Perf. (%)
€262.00
17.01.24
€286.92
17.01.25
34.24%
26.07.24

Robert W. Baird 
17.01.24 50%